Article

Secondary tumors of the gastrointestinal tract

Institut für Pathologie, Medizinische Universität Graz, Auenbruggerplatz 25, 8036, Graz, Österreich.
Der Pathologe (Impact Factor: 0.64). 02/2012; 33(1):45-52. DOI: 10.1007/s00292-011-1544-x
Source: PubMed

ABSTRACT Metastatic involvement of the gastrointestinal tract is rare and may cause considerable difficulties with respect to differential diagnosis. The gastrointestinal tract may either be affected by direct invasion, intraperitoneal dissemination or hematogenous cancer spread, the latter most often originating from malignant melanoma, breast and lung carcinomas. Metastatic deposits primarily develop within the submucosa. Secondary involvement of the mucosa typically leads to centrally depressed and/or ulcerated (volcano-like) nodular lesions. In histology, lack of a mucosal in situ component favors diagnosis of metastasis, whereas presence of an adenomatous precursor lesion is regarded to be characteristic of primary tumors. This concept, however, has recently been challenged by demonstrating metastatic cancer growth along intact basement membranes within the mucosal layer, i.e. mucosal colonization. The histopathological, immunohistochemical and clinical features of secondary gastrointestinal tumors are discussed in detail, focusing on criteria for differential diagnosis. The prognosis of affected patients is generally poor.

0 Bookmarks
 · 
82 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clear cell sarcoma (soft-part melanoma) is a very rare entity with a distinctive histopathologic and molecular profile. Herein, we present the sixth reported case of a primary gastrointestinal clear cell sarcoma discovered in a 21-year-old woman. The patient underwent numerous tests prior to the diagnosis of her small bowel pathology, including the use of capsule endoscopy, which allowed for visualization and final localization of the tumour. Additionally, we discuss this rare type of sarcoma that affects young adults and has a poor prognosis characterized by the balanced chromosomal translocation t(12;22)(q13;q12) with special emphasis on the necessity for pathologists to be able to distinguish it from melanoma -- potentially a major pitfall in diagnosis.
    Apmis 11/2005; 113(10):716-9. DOI:10.1111/j.1600-0463.2005.apm_243.x · 1.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metastasis rarely occurs in the gastrointestinal tract (GIT). However, as progress regarding the treatment of cancers has occurred over recent years, the survival time of patients affected by advanced-stage cancers has increased. It could be expected that progressively more cancer patients with gastrointestinal symptoms would be presenting to gastroenterologists for diagnosis and further management. The aim of this study was to reveal the incidence, typical location and morphology of secondary tumors within the GIT. A retrospective study was conducted at the National Taiwan University Hospital from 1 January 1994 to 31 December 2003 inclusive in order to review the available data pertaining to diagnosed GIT metastases. Only those patients who had been checked by endoscopy and confirmed by histopathology were included. Details regarding patient clinical information, demographic data, treatment, histopathology, and eventual outcome were reviewed, recorded and analyzed. The incidence of GIT metastases was found to be one upper GIT metastasis per 3847 upper GIT endoscopies and one lower GIT metastasis per 1871 colonoscopies. The common locations for metastases to occur were duodenum and stomach. The general morphology of the observed metastatic lesions of the digestive tract identified them, mostly, as single and primary (mucosa-origin) carcinoma-like lesions. The survival interval from the diagnosis of GIT metastasis to patient death was statistically significantly longer in the aggressive-treatment group compared to the conservative-treatment group (Kaplan-Meier, P = 0.0004). Although metastatic lesions in the GIT are rare, they do occur. They usually present as single and primary carcinoma-like lesions, with the stomach and duodenum most commonly involved.
    Journal of Gastroenterology and Hepatology 07/2007; 22(6):827-31. DOI:10.1111/j.1440-1746.2006.04532.x · 3.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Breast carcinoma is the most common malignancy in women. Metastatic involvement of the stomach is not well known. Endoscopic features and treatment options were evaluated retrospectively for 51 patients with gastric metastases of breast carcinoma. The presenting sites of metastases were skeleton (43%), stomach (27%), lung (8%), and liver (4%). Diagnosis of gastric involvement was histologically confirmed in 41 patients and based on endoscopic features, despite negative biopsies in 10 patients. Six patients (12%) presented with nonfatal hemorrhage; in the others, symptoms were nonspecific: anorexia (71%), epigastric pain (53%), and vomiting (41%). Endoscopy showed 3 patterns: 18% localized lesions, 57% diffuse infiltration, and 25% external compression at the cardia or pylorus. Histology showed mainly lobular breast carcinoma (n = 36) compared with ductal carcinoma (n = 10) and other types (n = 5), contrary to the usual distribution. The overall response to systemic therapy was 46% (17 of 37 treated patients). Median survival from detection of gastric metastases was 10 months, with a 2-year survival rate of 23%. Gastric metastases usually derive from lobular rather than ductal breast carcinoma. Endoscopy revealed mainly a diffuse linitis plastica-like infiltration. Chemotherapy or hormonal treatment may result in fair palliation in selected patients, although many patients are heavily pretreated.
    Cancer 01/2001; 89(11):2214-21. DOI:10.1002/1097-0142(20001201)89:113.0.CO;2-D · 4.90 Impact Factor